4A.Oussalah,V.Laurent,O.Bruot,J.‐L.Guéant,D.Régent,M.‐A.Bigard,L.Peyrin‐Biroulet.Additional benefit of procalcitonin to C‐reactive protein to assess disease activity and severity in Crohn’s disease[J]. Alimentary Pharmacology & Therapeutics . 2010 (9)
5Kenneth L.Becker,RichardSnider,Eric S.Nylen.Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target[J]. British Journal of Pharmacology . 2010 (2)
6Andrew S. Neish.Microbes in Gastrointestinal Health and Disease[J]. Gastroenterology . 2009 (1)
7Kelvin Teck-Joo Thia,Edwin Shih-Yen Chan,Khoon-Lin Ling,Wai-Yoong Ng,Edward Jacob,Choon-Jin Ooi.Role of Procalcitonin in Infectious Gastroenteritis and Inflammatory Bowel Disease[J]. Digestive Diseases and Sciences . 2008 (11)
8Martijn D. Kruif,Lucienne C. Lemaire,Ida A. Giebelen,Joachim Struck,Nils G. Morgenthaler,Jana Papassotiriou,Peter J. Elliott,Tom Poll.The influence of corticosteroids on the release of novel biomarkers in human endotoxemia[J]. Intensive Care Medicine . 2008 (3)
9Geert D’Haens,William J. Sandborn,Brian G. Feagan,Karel Geboes,Stephen B. Hanauer,E. Jan Irvine,Marc Lémann,Philippe Marteau,Paul Rutgeerts,Jurgen Sch?lmerich,Lloyd R. Sutherland.<ce:link locator="fx1"/> A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis[J]. Gastroenterology . 2007 (2)
